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g.2013.0Abstract Most of the world’s populations residing in developing countries depend on alternative
medicine and use of plant ingredients. The plant Caesalpinia bonducella belongs to the family of
Caesalpiniaceae and it is commonly known as Natakaranja in Hindi. It contains bonducin and
two phytosterols namely sitosterol and hepatsane. The twigs and young leaves of C. bonducella
are rationally used for curing tumors, inﬂammation and liver disorders. In our present work alco-
holic extracts of this ayurvedic plant were tested for their antimutagenic and anticarcinogenic prop-
erties. The aim of the study is to investigate the antimutagenic and antigenotoxic potential of
alcoholic extracts of C. bonducella against methyl methane sulfonate (MMS) induced genotoxicity.
In this experiment we have used in vitro method i.e., human lymphocyte culture and in vivo method
in bone marrow cells of albino mice, while the parameters studied included chromosomal aberra-
tions (CA), sister chromatid exchanges (SCEs) and cell growth kinetics (RI) both in the presence
as well as in the absence of exogenous metabolic activation system for in vitro studies whereas total
aberrant cells and the frequencies of aberrations were used for in vivomethods. Alcoholic extracts of
C. bonducella signiﬁcantly reduce chromosomal aberration from 42.75%, 44.25%, and 51.75%
levels [at 24, 48, and 72 h due to methyl methane sulfonate (MMS)] to 28.50%, 30.25%, andsulfonate, CA, chromosomal
hange, RI, replication index,
olic extracts of Caesalpinia
2700920/3442.
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248 M.S. Ahmad et al.35.10%, respectively similarly sister chromatid exchanges were reduced from 7.70 ± 1.50 to
5.20 ± 1.50 at 48 h of treatment and replication index was enhanced in vitro for each concentration
and duration of treatment and their ameliorating potential was dose and duration dependent. Similarly
these extracts signiﬁcantly reduced the number of aberrant cells and frequency of aberrations per cell in
in vivo.
 2013 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
It is estimated that about 85% of people living in developing
countries depend on traditional medicine [1]. These are used
not just in rural areas of developing countries, but also in
developed countries where modern medicines are predomi-
nantly used [2]. Plants used in traditional medicine contain a
wide range of ingredients that can be used to treat chronic as
well as infectious diseases. The medicinal value of plants lies
in certain chemical substances that produce a deﬁnite physio-
logical action on the human body. The most important among
these bioactive compounds of plants are alkaloids, ﬂavonoids,
tannins and phenolic compounds [3].
Caesalpinia bonducella belongs to the family of Caesalpini-
aceae and is commonly known as Natakaranja in Hindi. It
contains bonducin, two phytosterols, namely sitosterol and
hepatsane along with alkaloids, ﬂavonoids, glycosides, sapo-
nins, tannins and triterpenoids [4,5]. The twigs and young
leaves of C. bonducella are tradionally used for the treatment
of tumors, inﬂammation and liver disorders. In addition, var-
ious parts of this plant have been reported to possess multiple
therapeutic properties like antiproliferatve [6], antidiabetic [7],
hepato-protective, antitumor and antioxidant activities [8].
The rich and diverse plant sources of India are likely to pro-
vide the effective anticancer agents. The best approaches in
searching for anticancer agents from plant resources are the
selection of plants based on ethno-medical leads and testing
the selected plants’ efﬁcacy and safety in the light of modern
science. Exploration of traditional medical practices in
Tamilnadu brought to light the ethnomedical use of young
leaves of C. bonducella to treat certain tumors in a few remote
villages in Kolli Hills, Nammakal district of Tamilnadu, India.
This plant is also known as an antitumor agent in Ayurveda,
an ancient system of medicine [9].
In Malaysia, the young leaves are used in the treatment of
intermittent fevers, and for expelling intestinal worms. In Cey-
lon, they are applied for toothache, and also given for worms
in children. In Guinea, the boiled leaves are used as a gargle
for sore throat [10]. Finely powdered leaves are prescribed as
a uterine tonic after child birth.
In studies done earlier [11], no signiﬁcant variation in the
body weight and weight of organs between the control and
the treated group was observed following 28 days of treatment.
Hematological analysis and clinical blood chemistry revealed
no toxic effects of the extract. Pathologically, neither gross
abnormalities nor histo-pathological changes were observed.
Further no mortality was recorded in 28 days. In the present
study, the acute toxicity studies of methanolic extract of C.
bonducella were conducted in albino mice as per the organiza-
tion for economic cooperation and development (OECD)
guidelines 420 where the limited test dose of 2 gm/kg was used.2. Materials and methods
The whole plants of C. bonducella were dried under shade at
room temperature. The shade dried plants were powdered;
around 60 gm of coarse powder was defatted with petroleum
ether and were extracted exhaustively with 95% methanol at
60 C. The extract was dried by vacuum evaporator. Methanolic
extract of C. bonducella was dissolved in dimethyl sulfoxide
(DMSO) to prepare different optimum concentration for studies.
2.1. In vivo method
Albino mice 8–10 weeks old (25–35 gm in weight) were ex-
posed to different test chemicals by appropriate routes (intra
peritoneal i.e., I.P injection) and were sacriﬁced at sequential
intervals of 16, 24, and 32 h of stipulated treatment time. Ani-
mals were treated with each test substance as shown in the ta-
bles. The samples were taken separately after each treatment as
mentioned above. The central sampling interval was 24 h, since
cell cycle kinetics could be inﬂuenced by test substances. The
early and late sampling intervals were adequately spaced with-
in the range of 6–48 h. The additional dose levels were tested in
subsequent experiments; these samples were taken at the pre-
determined duration.
2.1.1. Preparation of slides
Immediately after the albino mice were sacriﬁced, the bone
marrow contents were obtained by standard procedure and ex-
posed to hypotonic solution and cells were ﬁxed in Carnoy’s
ﬁxative. Chromosome preparations were made from bone
marrow cells following the standard procedure as described.
The stained slides were examined and metaphase cells were
scored for chromosomal aberrations. Prior to sacriﬁce, mice
were further treated with colchicines, a spindle inhibitor to ar-
rest the cells in C-metaphase. The slides were stained in 10%
aqueous Giemsa solution and 100 bone marrow metaphase
cells from each animal were scored under code. The types of
chromosomal aberrations considered were chromatid and
chromosome gaps, breaks, fragments, exchanges and pulveri-
zation (severely damaged cells). The reduction factors due to
test chemical treatments were calculated using the formula:
% Reduction
¼ ðAberrant cells in control aberrant cells in MMS and test chemicalsÞðAberrant cells in control aberrant cells in negative controlÞ
Control groups:
Concurrent positive and negative controls were included in
this study. Whereas the positive control includes a single dose
of MMS, a compound known to produce chromosomal aber-
rations in vivo, the negative control did not include any
treatment.
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Most of the cytogenetic studies were carried out involving the
examination of metaphase chromosomes. The evaluation of
chromosomal damage at metaphase stage gives a more precise
and detailed picture of the clastogenic agent than anaphase or
telophase stage. Human peripheral blood lymphocytes are ex-
tremely sensitive indicators of the in vitro assay system. The
chromosomal changes (numerical and structural) were utilized
for an investigation of the genotoxic as well as antigenotoxic
potentiality of test chemicals. The parameters studied included
chromosomal aberrations (CA), sister chromatid exchanges
(SCEs) and cell growth kinetics (RI) both in the pres-
ence and in the absence of exogenous metabolic activation
system.
2.2.1. Preparation of S9 liver/microsome fraction
The S9 liver/microsome fraction formed the exogenous meta-
bolic activation system utilized for the present investigation
and was prepared as follows.
2.2.1.1. Induction of rat liver enzyme. For preparing S9 fraction,
the standard procedures as recommended by Moron and Ames
[12] were followed. Swiss albino healthy rats (Wister strain, ob-
tained from animal house, Biotech, Varanasi, India) each
weighing about 200 gm were given 0.1% (1 mg/ml) of pheno-
barbital in drinking water for one week for the induction of li-
ver enzymatic activities.
2.2.1.2. Removal of livers from the rats. The rats were sacriﬁced
through cervical dislocation. In order to ensure the sterility of
S9 preparation, the livers were removed aseptically using sterile
surgical tools in a laminar ﬂow cabinet. Utmost care was taken
to avoid a cut across the esophagus or the intestine, which
could otherwise cause the contamination of liver homogenate.
The removed livers were immediately placed in 0.15 M KCl
chilled solution in a culture tube.
2.2.1.3. Preparation of liver homogenate fraction. The whole
procedure was carried out at 0–4 C using sterilized solutions
and glasswares. The livers were washed in chilled KCl several
times to remove traces of hemoglobin, which inhibits enzyme
activity. The washed livers were transferred to a beaker con-
taining three volumes of 0.15 M KCl (3 ml/g wet liver) and
after mincing with a sterile scissors, these were homogenized
by a tissue homogenizer at 4 C. The homogenate was centri-
fuged in a refrigerated centrifuge for 10 min at 9000 rpm.
The supernatant (S9 fraction) was decanted and saved as
1 ml aliquots in polypropylene storage vials and stored in li-
quid nitrogen till further use.
2.2.1.4. Preparation of S9 mix. The S9 fraction was prepared
freshly every time for use in the culture. The S9 fraction was
complemented with 8 lM NADP, 100 lM Na2HPO4 of buffer
at 7.4 pH. About 0.8 ml of S9 mix was added every time along
with the test chemicals to the cultures.
2.2.2. Chromosomal aberrations
2.2.2.1. Preparation of culture media. Tissue culture medium
RPMI–1640 (ﬂow laboratories) with L-glutamine and Hepes
buffer without NaHCO3 was prepared in advance and storedat 4 C, but the storage period never lasted longer than a week.
About 1.574 gm of medium was dissolved in 100 ml of double
distilled water by gentle shaking. Antibiotics, penicillin
(100 IU/ml) and streptomycin (100 IU/ml) (Hoechst) were also
added and pH was adjusted at 6.8–7.2 with N/10 NaHCO3 and
HCl. The medium was ﬁltered and sterilized using Millipore
ﬁltration assembly by 0.45 lmMillipore size. The ﬁltered med-
ium was then stored in sterilized tightly capped glass bottles.
2.2.2.2. Collection of blood samples. Peripheral blood from the
healthy donors was taken fresh every time through veinal
puncture under aseptic conditions (disposable needle and dis-
posable syringes, Unitech) and Heparin (500 IU/ml; Micro
Lab) was used as anticoagulant. The tightly capped glass vials
were gently mixed and stored at 4 C for half an hour to sep-
arate blood cells from plasma.
2.2.2.3. Setting of the cultures. Lymphocyte culture was carried
out by adding 0.8 ml of plasma containing white blood cells
(WBC) in 4.5 ml of culture medium supplemented with
0.1 ml phytohemagglutinin–P (PHA–P, Micro lab) and 15%
fetal calf serum (Gibco). The culture vials were then tightly
capped to avoid CO2 loss and after gently mixing, culture
tubes were incubated at 37 C in dark and colchicine was
added 2 h prior to harvesting for arresting the cells at meta-
phase stage.
2.2.2.4. Harvesting of the cultures. After appropriate durations,
the cultures were taken out from the incubator and their con-
tents, after gentle shaking, were transferred to a centrifuge
tube, the cells were spun down by centrifugation for 10 min,
at 1200 rpm, and pellets saved by discarding the supernatant.
Hypotonic treatment (0.075 M KCl) was carried for 10–
12 min at 37 C and the cells were recollected by centrifuga-
tion. The cell pellet was suspended in 5 ml of freshly prepared
chilled ﬁxative (3:1 of methanol and acetic acid), which was
added drop by drop with a pipette while continuously shaking
the tube to avoid formation of clots. In order to ensure proper
ﬁxation, the cells were kept suspended in the ﬁxative for a min-
imum period of one hour though preferably overnight. Three
changes with fresh ﬁxative were given before preparing the
slides.
2.2.2.5. Slide preparation and staining. After giving ﬁnal wash-
ing in the ﬁxative, the cells were re-suspended in 0.2 ml of
fresh ﬁxative. Two or three drops of cell preparation were
dropped over clean, grease free, pre-chilled and wet micro-
scopic slides and air-dried. One-day-old slides were stained
in Giemsa (Sigma) for 15 min and rinsed in 95% alcohol
and ﬁnally in the absolute alcohol for proper differentiation.
After proper air-drying these slides were dipped in xylene
for 5 min before mounting in dibutyl phathalate xylene
(DPX).
2.2.2.6. Analysis of the cells. In order to avoid the bias in scor-
ing the chromosomal anomalies before and after treatment of
different test chemicals, all slides were coded prior to scoring.
A total of 300 well spread metaphase cells were analyzed for
each concentration of the test chemicals and for each time of
duration to analyze various chromosome and chromatid type
aberrations using the method of Evans [13].
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Sister chromatid exchange is a sensitive rapid and objective
method of observing reciprocal exchange between sister chro-
matids. This method depends upon the phenomenon of 5-bro-
mo-2-deoxyuridine (BrdU) incorporation into DNA in place
of thymidine. After two rounds of cell division, the chromatids
were labeled with BrdU and consequently differentially stained
with Hoechst. The BrdU incorporation quenches the ﬂuores-
cence of 33,258 Hoechst. Therefore, the light energy is ab-
sorbed but not emitted by such dyes, which results in the
reduced staining of chromatid with Giemsa [14].
2.2.3.1. Labeling of chromosomes with BrdU. The sister chro-
matid exchange analysis was carried out following the stan-
dard procedure of Latt et al. [15]. The cells in the culture
were exposed to nucleoside, BrdU (Sigma) after 24 h of culture
initiation at the ﬁnal concentration of 2 lg ml. The culture
vials were tightly capped and covered with an aluminum foil
to avoid light exposure and incubated at 37 C for another
48 h in dark.
2.2.3.2. Slide preparation and staining. After 2 h of colchicine
treatment, the cultures were harvested and processed following
the same method as described for the chromosomal aberration
analysis. For the differential staining of SCEs the methods of
Latt et al. [15] with slight modiﬁcations were followed. One-
day-old slides were dipped in 0.5 lg/ml of 33,258 Hoechst stain
(Sigma) dissolved in double distilled water in a horizontal cou-
plin jar. The slides were then put in a ﬂat glass dish with the
layer of cells facing upward. These were covered with a thick
layer (2–3 cm) of phosphate buffer (pH 6.8) and exposed to
UV lamp (15 W, 254 lm, Philips) from a distance of 10–
15 cm for 30–45 min. The slides were taken out from the buf-
fer, washed twice in double distilled water and air-dried. These
were then incubated in 2· SSC (0.3 M NaCl, 0.03 M sodium
citrate, pH 7.0) at 65 C in water both for 90 min using vertical
couplin jars. The slides were taken out and rinsed in distilled
water. The air-dried slides were then stained in Giemsa for
20 min and rinsed in 90% alcohol followed by rinsing in abso-
lute alcohol. The dried slides were dipped in xylene for 5 min
and mounted in DPX.
2.2.3.3. Analyses of the cells. All slides were coded prior to
scoring so as to avoid any ambiguity. Around 50 metaphases
(25 metaphases/donor) with differentially stained chromatids
were scored for each test chemical treatment in the absence
of S9 mix and 50 metaphases were scored for each treatment
in the presence of S9 mix. The interstitial exchanges between
two sister chromatids were scored as two exchanges and the
terminal exchanges were scored as a single exchange. Student’s
‘t’ test was applied for calculating the signiﬁcance of difference
between the treated and the controls.
2.2.4. Cell cycle kinetics analysis
The cells undergoing ﬁrst (M1) second (M2) and third (M3)
divisions were detected by studying the BrdU labeled and dif-
ferentially stained chromosomes, following the method of
Crossen and Morgan [16]. The cells with both the chromatids
being darkly stained were scored as M1 cells, those with one
dark and one lightly stained chromatid were taken as M2 cells
and those having a mixture of both the differentially stainedand uniformly stained chromatids were scored as M3 meta-
phase. Around 100 well spread metaphases were scored for
each concentration and each treatment of duration from each
donor in the absence as well as in the presence of S9 mix. The
replication index (RI) was calculated according to the formula
of Tice et al. [17] as given below. The deviation from the con-
trols was determined by using Chi-square (v2) test.
R:I ¼ ðM1X1Þ þ ðM2X2Þ þ ðM3X3Þ
1002.3. Statistical analysis
Standard deviation (SD) and standard error (SE) were calcu-
lated using the following formula.
Mean ð XÞ ¼ RX
n
Variance d2 ¼ RðX
2n:X2Þ
n 1
S:D:ðdÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
RX2  nX2
n 1
s
SE ¼ SDﬃﬃﬃ
n
p
where,
X= variable.
N= number of observation.
RX2 = sum of square of individual variables.
X =mean of variables.
d= standard deviation.
Chi-square (v2) test for homogeneity test of variance was used
to analyze the cell growth kinetics exchange with the normal
control. The level of signiﬁcance was tested from standard sta-
tistical tables of Fisher and Yates [18].
Student’s two-tailed ‘t’ test was used for calculating the sta-
tistical signiﬁcance in SCE and chromosomal aberrations by
comparing the effect induced by different test chemicals with
the respective control. The following formula was used for this
purpose.
t ¼
XðcontrolÞ  XðtreatedÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðSE of controlÞ2 þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðSE of treatedÞ2
qr
The statistical signiﬁcance was calculated from Fisher and
Yates table at (n1 + n2  2) degree of freedom (df) at 0.05%
level of signiﬁcance.
2.4. Table of chemical concentration
(A) Control
Positive and negative control Concentrations
MMS 5 lg/ml
Dimethyl sulfoxide (DMSO) 5 lg/ml
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Phytoproducts
(mg/kg bw)
1st dose 2nd dose 3rd dose 4th dose 5th dose
Caesalpinia
extracts
CE1 200 CE2 250 CE3 300 CE4 350 CE5 400Table 1 Effec
methyl methan
Treatment
DH2O
DMSO
MMS
Caesalpinia extr
MMS+ Caesal
Note: CE, conc
dimethylsulfoxid
* Signiﬁcant att of alcoh
e sulfonat
act
pinia extra
entrations
e; DH2O,
<0.05 proolic extra
e.
Caesal
(Y/kg
0
0
0
CE5
ct CE1
CE2
CE3
CE4
CE5
of alcohol
distilled w
bability. Ycts of Ca
pinia
bw)
Cel
chr
00
00
14
00
11
09
07
08
09
ic extracts
ater. Calcu
/kg bw is tesalpinia b
l with pul
omosome
of Caesalp
lations we
he concenFigure 1 Shows effects of ﬁve increasing concentrations of(C) In vitro concentrations of phyto-chemicals
Phyto-products
(lg/ml)
1st dose 2nd dose 3rd dose 4th dose
Caesalpinia
extracts
CE1 150 CE2 200 CE3 250 CE4 300alcoholic extracts of Caesalpinia bonducella (CE) at 16, 24, and32 h of treatment durations in the bone marrow cells of albino
mice in vivo against methyl methane (MMS) induced clastogeny.3. Results
3.1. In vivo effects
In these in vivo experiments we have selected ﬁve most opti-
mum concentrations of alcoholic extract of Caesalpinia and
their effects on chromosomal aberrations given at three differ-
ent durations were calculated and are presented in the tables.
As shown in Table 1 for 16 h of treatment duration, the
percentage of aberrant cells were 11.0% due to treatment with
MMS which were reduced to 8.6%, 7.9%, 7.0%, 6.7%, and
6.3% respectively for ﬁve consecutive concentrations of Cae-
salpinia extract. The fragment types of aberrations were most
prominent followed by breaks and gaps. Similarly reduction in
the frequencies of aberrations put the values at 11.34%,
18.55%, 27.83%, 30.92%, and 35.05% against ﬁve different
concentrations of Caesalpinia extract respectively. The trend
of effects was linear i.e., as concentration of Caesalpinia ex-
tract increases the effect also increases (Fig. 1). The gross effect
on the total number of frequencies per thousand cells was 155,
132, 115, 105 and 92 of ﬁve different concentrations of Cae-
salpinia extract against 199 of MMS alone. The normal values
were 23 for distilled water treatment and 35 and 47 for DMSO
and Caesalpinia extract treatment alone (Table 2).onducella on t
verized Types
Gaps
01
03
49
04
44
43
36
31
28
inia bonducella
re made at 16 h
tration of alcohWhen the treatment duration was increased to 24 h, the ef-
fects were similar, with increasing values. The observed values
were 9.3%, 8.5%, 8.1%, 7.6%, and 6.9% due to ﬁve increasing
concentrations of Caesalpinia extract, against 11.0% of MMS
alone. The normal values were 3.0%, 3.5%, and 3.5% for pure
water, DMSO and Caesalpinia extract alone respectively. It
also shows dose–response relationship (Table 3). Effects of
Caesalpinia extract on the frequency of aberrations per cell
and total aberrations noticed were not different statistically.
The total aberrations per thousand cells were 182, 152, 157,
153, and 135 for Caesalpinia extract against the value of 230
with MMS alone (Table 4).
At 32 h of treatment, we observed the percentage of aber-
rant cells as 12.0% for MMS alone, and 11.0%, 10.3%,
9.7%, 9.3%, and 8.9% respectively for ﬁve different concen-
trations of Caesalpinia extract given with MMS, whereas the
values for normal control was 3.1%, and the same for DMSO
and Caesalpinia extract alone (respectively) were 3.2% and
3.2%. In terms of the effects on the percent reduction in aber-
rant cells, the values were 8.33%, 14.16%, 19.16%, 22.50%,
and 25.83% respectively. These values were statistically signif-
icant at <0.05 probability level due to Caesalpinia extract on
the number and percentage of aberrant cells. It also showedhe frequency of cells with chromosome aberrations induced by
of chromatic aberrations Aberrant cell no.
percentage (%)
(%) Reduction
Breaks Fragments Exchange
01 21 00 22 (2.2)
02 30 00 32 (3.2)
50 41 05 110 (11.0)
03 40 00 43 (4.3)
38 32 05 86 (8.6) 11.34
35 31 04 79 (7.9) 18.55
30 32 01 70 (7.0) 27.83*
27 30 02 67 (6.7) 30.92*
23 28 03 63 (6.3) 35.05*
; MMS, methyl methane sulfonate 5 lg/ml/kg body weight; DMSO,
of treatment, excluding the gaps type of aberration.
olic extracts of Caesalpinia bonducella.
Table 3 Effect of alcoholic extracts of Caesalpinia bonducella on the frequency of cells with chromosome aberrations induced by
methyl methane sulfonate at 24 h of treatment.
Treatment Caesalpinia conc.
(Y/kg bw)
Cell with pulverized
chromosome
Types of chromatic aberrations Aberrant
cell no. (%)
(%) Reduction
Gaps Breaks Fragments Exchange
DH2O 0 0 2 3 27 0 30 (3.0)
DH2O+ DMSO 0 0 3 3 32 0 35 (3.5)
MMS 0 11 32 51 45 3 110 (11.0)
Caesalpinia CE5 0 1 2 32 0 35 (3.5)
MMS+ Caesalpinia extract CE1 10 38 37 42 4 93 (9.3) 15.45
CE2 8 35 30 43 4 85 (8.5) 22.72
CE3 7 40 36 35 3 81 (8.1) 26.36
*
CE4 7 35 39 27 3 76 (7.6) 30.90
*
CE5 7 29 32 30 0 69 (6.9) 40.00
*
Note: CE, concentrations of alcoholic extracts of Caesalpinia bonducella; MMS, methyl methane sulfonate 5 lg/ml/kg body weight; DMSO,
dimethylsulfoxide, DH2O, distilled water. Calculations were made at 24 h of treatment, excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability. Y/kg bw is the concentration of alcoholic extracts of Caesalpinia bonducella.
Table 2 Effect of alcoholic extracts of Caesalpinia bonducella on the total number and types of frequency of cells with chromosome
aberrations induced by MMS.
Treatment Caesalpinia
(Y/kg bw)
Cell with aberration Total number
of aberration
0 1 2 3 4 5 6–9
DH2O 0 988 19 02 00 00 00 00 23
DMSO 0 978 29 03 00 00 00 00 35
MMS 0 890 61 30 08 06 03 02 199
Caesalpinia CE5 957 39 04 00 00 00 00 47
MMS+ Caesalpinia extract CE1 914 48 25 05 04 02 02 155
CE2 921 50 18 04 04 02 01 132
*
CE3 930 45 17 02 03 02 01 115
*
CE4 933 44 16 03 02 01 01 105
*
CE5 937 43 15 02 02 01 00 92
*
Note: CE, concentrations of alcoholic extracts of Caesalpinia bonducella; MMS, methyl methane sulfonate 5 lg/ml/kg bw; DMSO, dimethyl-
sulfoxide; DH2O, distilled water. Calculations were made at 16 h of treatment, excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability. The animals were sacriﬁced 16 h after MMS treatment 1000 cells from 10 animals were analyzed for each
point. Y/kg bw is the concentration of alcoholic extracts of Caesalpinia bonducella.
Table 4 Effect of alcoholic extracts of Caesalpinia bonducella on the total number and types of frequency of cells with chromosome
aberrations induced by MMS.
Treatment Caesalpinia
(Y/kg bw)
Cell with aberration Total number
of aberration
0 1 2 3 4 5 6–9
DH2O 00 970 28 02 00 00 00 00 32
DH2O+ DMSO 00 965 32 03 00 00 00 00 38
MMS 00 890 69 16 09 07 03 06 230
Caesalpinia CE5 965 31 04 00 00 00 00 39
MMS+ Caesalpinia extract CE1 907 58 15 08 04 03 05 182
CE2 915 57 12 06 04 03 03 152
*
CE3 919 53 13 04 03 03 05 157
*
CE4 924 45 14 06 05 02 04 153
*
CE5 931 40 11 06 04 03 05 135
*
Note: CE, concentrations of alcoholic extracts of Caesalpinia bonducella; MMS, methyl methane sulfonate 5 lg/ml/kg body weight; DMSO,
dimethylsulfoxide; DH2O, distilled water. Calculations were made at 24 h of treatment, excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability level. The animals were sacriﬁced 24 h after MMS treatment 1000 cells from 10 animals were analyzed for
each point. Y/kg bw is the concentration of alcoholic extracts of Caesalpinia bonducella.
252 M.S. Ahmad et al.almost dose dependent relationship, though the highest doses
were not much effective in comparison with the preceding
dose. More of chromosomal exchange types of aberrationswere seen in contrast to the previous two durations of treat-
ment (Table 5 and Fig. 1). The total frequencies per thousand
cells were 233 for MMS only and 202, 179, 158, 154, and 149
Table 5 Effect of alcoholic extracts of Caesalpinia bonducella on the frequency of cells with chromosome aberrations induced by
methyl methane sulfonate at 32 h of treatment.
Treatment Caesalpinia
(Y/kg bw)
Cell with pulverized
chromosome
Types of chromatic aberrations Aberrant
cell no. (%)
% Reductions
(%) Red
Gaps Breaks Fragments Exchange
DH2O 00 00 02 03 28 00 31 (3.1)
DH2O+ DMSO 00 00 04 02 30 00 32 (3.2)
MMS 00 13 37 54 48 05 120 (12.0)
Caesalpinia CE5 00 03 03 29 00 32 (3.2)
MMS+ Caesalpinia extract CE1 11 38 46 48 05 110 (11.0) 8.33
CE2 09 36 41 48 05 103 (10.3) 14.16
CE3 10 31 37 46 04 97 (9.7) 19.16
CE4 08 29 33 50 02 93 (9.3) 22.50
*
CE5 07 24 30 52 00 89 (8.9) 25.83
*
Note: CE, concentrations of alcoholic extracts of Caesalpinia bonducella; MMS, methyl methane sulfonate 5 lg/ml/kg body weight; DMSO,
dimethylsulfoxide; DH2O, distilled water. Calculations were made at 32 h of treatment, excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability level. Y/kg bw is the concentration of alcoholic extracts of Caesalpinia bonducella.
Table 6 Effect of alcoholic extracts of Caesalpinia bonducella on the total number and types of frequency of cells with chromosome
aberrations induced by MMS.
Treatment Caesalpinia conc.
(Y/kg bw)
Cell with aberration Total number of
aberration
0 1 2 3 4 5 6–9
DH2O 00 969 25 06 00 00 00 00 37
DH2O+ DMSO 00 968 26 06 00 00 00 00 38
MMS 00 880 77 20 05 07 05 06 233
Caesalpinia CE5 968 28 04 00 00 00 00 36
MMS+ Caesalpinia extract CE1 890 72 19 05 05 05 04 202
CE2 897 68 20 05 04 03 03 179
CE3 903 67 18 04 03 03 02 158
*
CE4 907 65 17 03 03 02 03 154
*
CE5 911 60 19 02 03 04 01 149
*
Note: CE, concentrations of alcoholic extracts of Caesalpinia bonducella; MMS, methyl methane sulfonate 5 lg/ml/kg body weight; DMSO,
dimethylsulfoxide; DH2O, distilled water. Calculations were made at 32 h of treatment, excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability. The animals were sacriﬁced 32 h after MMS treatment 1000 cells from 10 animals were analyzed for each
point. Y/kg bw is the concentration of alcoholic extracts of Caesalpinia bonducella.
Does Caesalpinia bonducella ameliorate genotoxicity? An in vitro study in human lymphocyte culture 253respectively for Caesalpinia extract along with MMS. These
signiﬁcantly reduced values show the effects of Caesalpinia ex-
tract on the total aberrations as well as aberrations per cell as
shown in Table 6.
3.2. In vitro effects
Here the culture treated with methyl methane sulfonate
(MMS) resulted in clastogenic abnormalities as observed in
percent metaphase aberration, types of aberrations and aber-
ration per cell (42.75%, 44.25%, and 51.75% or 0.43, 0.44
and 0.52 aberration per cell) at single standard dose and three
durations viz., 24, 48, and 72 h respectively whereas, with con-
trol, the normal and DMSO plus Caesalpinia extract, these
values were (0.05, 0.05) per cell. Caesalpinia extracts bring
down aberrations from 42.75% to 37.75%, 33.75%, 31.25%,
and 28.50% with four consecutive doses of the extract at
24 h of duration, whereas at 48 h, it get lowered from
44.25% to 41.00%, 35.85%, 33.00%, and 30.25% by adminis-
tration of 1st to 4th concentrations of Caesalpinia extract
respectively. The same trends were noticed, when the treatment
durations were increased to 72 h. These values showed linearlyincreasing trends with doses, but it does not depend on dura-
tions. The maximum percentage reductions in the aberrations
were 33.33 for 24 h and 31.63 and 32.17 respectively for 48 and
72 h that were caused by highest doses of Caesalpinia extract
(Table 7 Fig. 2).
Similarly when the experiment was setup along with meta-
bolic activation system (+S9 mix) the effect of MMS got in-
creased. The effect of Caesalpinia extract also showed a
similar trend; they lower the clastogenic activity of MMS.
These values show linear increases with doses (Table 8). The
maximum effective percentage reductions were 32.65%,
33.11%, and 33.07% for 24, 48 and 72 h respectively. When
sister chromatid exchanges were counted (Tables 9 and 10)
the reduction was evident both in the absence as well as in
the presence of metabolic activation; there being a lowering
of the mean range and the total SCEs and SCE per cell from
07.70 to 05.20 and from 07.00 to 05.10. For the analysis of
SCE, only 48 h of cultures were used and 50 metaphases were
scanned. The effects of Caesalpinia extract on replication index
(Tables 11 and 12) showed an elevated level when compared
with the MMS treatment alone i.e., from 1.51 to 1.66, though
still being lower than the normal level of 1.76. The effect, after
Table 7 Analysis of chromosomal aberrations after treatment with methyl methane sulfonate along with alcoholic extracts of
Caesalpinia bonducella in vitro in the absence of metabolic activation (S9 mix.).
Treatments Durations (h) Metaphase
scored
Percent aberration metaphase Types of aberration (%) Aberration/
cell ± SE
Including gaps Excluding gaps Chromatid Chromosome Total
MMS 24 200 29.25 26.75 27.50 15.25 42.75 0.43 ± 0.04
48 200 30.35 22.25 30.25 14.00 44.25 0.44 ± 0.05
72 200 39.25 33.50 31.50 20.25 51.75 0.52 ± 0.06
MMS+ CE1 24 200 27.35 23.50 23.50 14.25 37.75 0.38 ± 0.04
48 200 29.50 21.25 30.50 10.50 41.00 0.41 ± 0.05
72 200 37.00 30.50 31.00 17.25 48.25 0.48 ± 0.05
MMS+ CE2 24 200 25.25 21.50 24.25 13.50 33.75 0.34 ± 0.03
48 200 27.50 19.50 28.75 12.25 35.85 0.36 ± 0.04
72 200 32.75 29.25 29.50 18.75 43.50 0.44 ± 0.05*
MMS+ CE3 24 200 23.00 19.25 20.75 10.50 31.25 0.31 ± 0.03
*
48 200 25.50 17.50 23.25 9.75 33.00 0.33 ± 0.03*
72 200 30.25 26.50 25.50 14.25 39.75 0.40 ± 0.04*
MMS+ CE4 24 200 21.50 17.75 19.25 9.25 28.50 0.29 ± 0.03
*
48 200 23.25 15.25 21.50 8.75 30.25 0.30 ± 0.03*
72 200 29.50 23.50 22.75 12.35 35.10 0.35 ± 0.04*
Control
Normal 72 200 4.00 1.50 3.50 1.00 4.50 0.05 ± 0.01
DMSO+ CE2 72 200 4.50 1.50 3.25 1.50 4.75 0.05 ± 0.01
Note: SE, standard error; CE, concentrations of alcoholic extracts of Caesalpinia bonducella; DMSO, dimethylsulfoxide; DH2O, distilled water;
MMS, methyl methane sulfonate 5 lg/ml/culture. Calculations were made excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability level.
Figure 2 Shows effects of four increasing concentrations of
alcoholic extracts of Caesalpinia bonducella (CE) at 24, 48, and
72 h of treatment durations in the human lymphocytes in vitro
against methyl methane (MMS) induced clastogeny.
254 M.S. Ahmad et al.treatment with metabolic activation system, shows the level
from 1.36 to 1.56, i.e., again being much effective in compari-
son to that without metabolic activation system.
4. Discussion
Methanolic extract of C. bonducella (MECB) signiﬁcantly re-
duces the elevated levels of lipid peroxidation and increases
the glutathione content in Ehrlich ascites carcinoma (EAC)-
treated mice, the anti-tumerogenic effect of MECB may in fact
be due to the antioxidant status and the free radical quenching
property of the phyto-constituents of MECB.The nitric oxide scavenging activity of ethanol extracts of
C. bonducella showed the percentage inhibition of
58.16 ± 0.37 when compared with the standard ascorbic acid
whose effect seems to be as effective as 36.71 ± 3.21 at a con-
centration of 25 lg/ml. The seed extracts of C. bonducella pres-
ent the result as 102.65 gm/ml [19]. The IC50 value of nitric
oxide scavenging activity of the methanol leaf extract of C.
bonducella was found to be as good as 102.8 gm/ml, when com-
pared with the standard curcumin value of 20.4 gm/ml [20].
The methanol extract of C. bonducella (Caesalpiniaceae)
leaves (MECB) were evaluated for antitumor activity against
Ehrlich ascites carcinoma (EAC)-bearing Swiss albino mice.
MECB caused a signiﬁcant (P< 0.01) decrease in tumor vol-
ume, packed cell volume, and viable cell count; and it pro-
longed the life span of EAC-tumor bearing mice.
Hematological proﬁle was converted to more or less normal
levels in the mice treated with extract. MECB signiﬁcantly
(P< 0.05) decreased the levels of lipid peroxidation and sig-
niﬁcantly (P< 0.05) increased the levels of glutathione reduc-
tase, Superoxide dismutase and catalase. The results indicate
that MECB exhibited a signiﬁcant antitumor and antioxidant
activity in EAC-bearing mice [20].
The ethanolic extract also inhibited the hydroxyl radical,
nitric oxide, superoxide anions with IC50 (half maximal inhib-
itory concentration) values of 109.85, 102.65, and 89.84l gm/
ml, respectively. However, the IC values for the standard
ascorbic acid were noted to be 70.79, 65.98, and 36.68 gm/ml
respectively. The results obtained in our study may indicate
that C. bonducella has a signiﬁcant potential to be used as a
natural antioxidant agent that decreases the number and fre-
quencies of chromosomal aberrations and sister chromatid ex-
change and enhances the replication indices.
These studies are conducted in the mice evaluating the
in vivo immunomodulatory activities of the aqueous extract
Table 8 Analysis of chromosomal aberrations after treatment with methyl methane sulfonate along with alcoholic extracts of
Caesalpinia bonducella in vitro in the presence of metabolic activation (+S9 mix.).
Treatments Durations (h) Metaphase
scored
Percent aberration metaphase Types of aberration (%) Aberration/cell ± SE
Including gaps Excluding gaps Chromatid Chromosome Total
MMS 24 200 25.50 22.50 23.50 13.25 36.75 0.37 ± 0.04
48 200 26.25 18.75 27.25 11.25 38.50 0.39 ± 0.04
72 200 35.50 29.25 28.50 16.25 44.75 0.45 ± 0.05
MMS+ CE1 24 200 24.35 20.50 21.25 11.25 32.50 0.33 ± 0.03
48 200 25.50 18.25 24.75 10.50 35.25 0.35 ± 0.03
72 200 34.75 27.25 25.50 14.35 39.85 0.40 ± 0.04
MMS+ CE2 24 200 22.50 18.25 18.75 10.50 29.25 0.29 ± 0.03
*
48 200 24.25 16.50 22.25 9.25 31.50 0.32 ± 0.03*
72 200 29.75 25.75 24.50 12.25 36.75 0.37 ± 0.04*
MMS+ CE3 24 200 19.25 16.25 17.25 9.25 26.50 0.27 ± 0.03
*
48 200 21.50 13.50 19.35 8.75 28.10 0.28 ± 0.03*
72 200 26.75 23.25 21.50 11.75 33.25 0.33 ± 0.03*
MMS+ CE4 24 200 14.75 15.25 16.25 8.50 24.75 0.25 ± 0.03
*
48 200 12.25 18.50 18.50 7.25 25.75 0.26 ± 0.03*
72 200 19.75 19.75 19.75 10.25 29.95 0.30 ± 0.03*
Control
Normal 72 200 3.50 2.00 2.00 1.50 3.50 0.04 ± 0.01
DMSO+ CE2 72 200 4.00 1.50 2.25 1.75 4.00 0.04 ± 0.01
Note: SE, standard error; CE, concentrations of alcoholic extracts of Caesalpinia bonducella; DMSO, dimethylsulfoxide; DH2O, distilled water;
MMS, methyl methane sulfonate 5 lg/ml/culture. Calculations were made excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability level.
Table 9 Analysis of sister chromatid exchange after treatment with methyl methane sulfonate along with alcoholic extracts of
Caesalpinia bonducella in vitro, in the absence of metabolic activation (S9 mix.).
Treatment Duration(h) Metaphase scored Total Range SCE/cell ± SE
MMS 48 50 385 2–12 7.70 ± 1.50
MMS+ CE1 48 50 350 1–11 7.00 ± 1.50
MMS+ CE2 48 50 325 1–11 6.50 ± 1.40
MMS+ CE3 48 50 295 1–10 5.90 ± 1.40
*
MMS+ CE4 48 50 260 2–9 5.20 ± 1.20
*
Control
Normal 48 50 94 0–4 1.88 ± 0.50
DMSO 48 50 96 0–5 1.92 ± 0.50
DMSO+ CE2 48 50 95 0–5 1.90 ± 0.50
Note: SCE, sister chromatid exchange; SE, standard error; CE, concentrations of alcoholic extracts of Caesalpinia bonducella; DMSO,
dimethylsulfoxide; DH2O, distilled water; MMS, methyl methane sulfonate 5 lg/ml/culture.
* Signiﬁcant at <0.05 probability level.
Table 10 Analysis of sister chromatid exchange after treatment with methyl methane sulfonate along with alcoholic extracts of
Caesalpinia bonducella in vitro, in the presence of +S9 mix.
Treatment Duration (h) Metaphase scored Total Range SCE/cell ± SE
MMS 48 50 350 1–11 7.00 ± 1.50
MMS+ CE1 48 50 315 1–10 6.30 ± 1.50
MMS+ CE2 48 50 285 1–10 5.70 ± 1.40
*
MMS+ CE3 48 50 270 1–10 5.40 ± 1.40
*
MMS+ CE4 48 50 255 1–11 5.10 ± 1.20
*
Control
Normal 48 50 92 0–5 1.84 ± 0.50
DMSO 48 50 94 0–5 1.88 ± 0.50
DMSO+ CE2 48 50 93 0–5 1.86 ± 0.50
Note: SCE, sister chromatid exchange; SE, Standard error; CE, concentrations of alcoholic extracts of Caesalpinia bonducella; DMSO,
dimethylsulfoxide; DH2O, distilled water; MMS, methyl methane sulfonate 5 lg/ml/culture.
* Signiﬁcant at <0.05 probability level.
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Table 12 Analysis of cell cycle kinetics after treatment with methyl methane sulfonate along with alcoholic extracts of Caesalpinia
bonducella, in vitro, in the presence of +S9 mix.
Treatment Cell scored (%) Cell in Replication index 2 · 3 Chi square test
M1 M2 M3
MMS 200 70 24 06 1.36
MMS+ CE1 200 66 27 07 1.41
MMS+ CE2 200 56 33 11 1.55 *Signiﬁcant
MMS+ CE3 200 53 35 12 1.59 *Signiﬁcant
MMS+ CE4 200 50 36 14 1.64 *Signiﬁcant
Control
Normal 200 42 43 15 1.73
DMSO 200 43 40 17 1.74
DMSO+ CE2 200 45 38 17 1.72
Note: 2 · 3 Chi square test were conducted, CE, concentrations of alcoholic extracts of Caesalpinia bonducella; DMSO, dimethylsulfoxide;
DH2O, distilled water; MMS, methyl methane sulfonate 5 lg/ml/culture.
* Signiﬁcant at <0.05 probability level.
Table 11 Analysis of cell cycle kinetics after treatment with methyl methane sulfonate along with alcoholic extracts of Caesalpinia
bonducella, in vitro, in the absence of metabolic activation (S9 mix.).
Treatment Cell scored (%) Cell in Replication index 2 · 3 Chi square test
M1 M2 M3
MMS 200 68 26 06 1.38
MMS+ CE1 200 63 32 05 1.42
MMS+ CE2 200 53 37 10 1.57
*Signiﬁcant
MMS+ CE3 200 49 38 13 1.64
*Signiﬁcant
MMS+ CE4 200 46 40 14 1.68
*Signiﬁcant
Control
Normal 200 40 44 16 1.76
DMSO 200 40 43 17 1.77
DMSO+ CE2 200 39 43 18 1.79
Note: 2 · 3 Chi square test were conducted, CE, concentrations of alcoholic extracts of Caesalpinia bonducella; DMSO, dimethylsulfoxide;
DH2O, distilled water; MMS, methyl methane sulfonate 5 lg/ml/culture.
* Signiﬁcant at <0.05 probability level.
256 M.S. Ahmad et al.of C. bonducella seeds. The aqueous extract of C. bonducella
seeds was tested for their effect on cell mediated and humoral
components of the immune system in rats and reported antiox-
idant activity in the chloroform extract of C. bonducella seeds
[19,21].
Mandal et al. [22], give the assessment of the antioxidant
role and reactive oxygen species scavenging activity of metha-
nolic extract of Caesalpinia leaf. It may be concluded that 70%
of the methanol extract of Caesalpinia crista leaves acts as an
antioxidant and reactive oxygen species (ROS) scavenger,
which may be due to the presence of phenolic and ﬂavonoid
compounds. It has been reported that antioxidant activity
and total phenolic content of ethanolic extract of C. bonducella
seeds are quite good. The results obtained in this study clearly
support our ﬁndings and indicate that C. bonducella has a sig-
niﬁcant potential to be used as a natural antioxidant as well as
antimutagenic and anticarcinogenic agent.
Compounds of cassane diterpenes were isolated from C.
bonducella and the isolated compounds were tested for their
antiproliferative activity against MCF-7 (breast adenocarci-
noma), DU145 (prostate carcinoma), C33A (Cervical carci-
noma) and Vero (African green monkey kidney ﬁbroblast)cells [6]. Gupta et al. [20], reported antitumor activity and anti-
oxidant status of C. bonducella against Ehrlich ascites carci-
noma in swiss albino mice. The methanol extract of C.
bonducella leaves (MECB) were evaluated for antitumor activ-
ity against Ehrlich ascites carcinoma (EAC)-bearing swiss albi-
no mice and reports indicate that MECB do exhibit signiﬁcant
antitumor and antioxidant activity in EAC-bearing mice.
Herbal medicines have received greater attention as an
alternative to clinical therapy and the demand for these reme-
dies has currently increased. An experimental screening meth-
od is important in order to ascertain the safety and efﬁcacy of
traditional and herbal products [23].
5. Conclusion
To conclude Caesalpinia extract acts as an effective anticlasto-
genic agent as it signiﬁcantly reduces the chromosomal aberra-
tions and sister chromatid exchange and enhances cell life as
indicated by replication indices in in vitro experiments. Simi-
larly, it reduces total aberrant cells and frequency of aberra-
tions in the albino mouse bone marrow cells in in vivo
experiments using MMS induced assay of clastogeny.
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